Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia

Comparison of Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia on Remifentanil Requirement in Desflurane Anesthesia

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06123637

Enrollment

Registered

2023-11-09

Start date

2024-01-02

Completion date

2024-12-30

Last updated

2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The primary purpose of this study is to compare the analgesia nociception index-guided anesthesia and standard anesthesia on remifentanil requirement in desflurane anesthesia.

Interventions

BEHAVIORALAnalgesia nociception index-guided anesthesia

Maintaining the blood pressure based on analgesia nociception index of \>50 value

BEHAVIORALStandard anesthesia

Maintaining the blood pressure based on anesthesiologist's decision

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of gastric cancer

Exclusion criteria

* Conversion to open laparotomy * Prior opioid abuse * Prior infection * Cardiac arrythmia

Design outcomes

Primary

Measure	Time frame	Description
Remifentanil requirement	at time of the end of skin suture (up to 4 hours)	Assessing the total dose of remifentanil administered from skin incision until skin suture

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026